509 results on '"Ying, Tianlei"'
Search Results
2. Author Correction: Pretrainable geometric graph neural network for antibody affinity maturation
3. Pretrainable geometric graph neural network for antibody affinity maturation
4. Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein
5. A homotrimeric GPCR architecture of the human cytomegalovirus revealed by cryo-EM
6. Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study
7. Single-domain antibodies as therapeutics for solid tumor treatment
8. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history
9. Progress in novel delivery technologies to improve efficacy of therapeutic antibodies
10. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment
11. Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
12. Half-Life Extension Enhances Drug Efficacy in Adeno-Associated Virus Delivered Gene Therapy
13. The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
14. A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors
15. An antigen-strengthened dye-modified fully-human-nanobody-based immunoprobe for second near infrared bioimaging of metastatic tumors
16. Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection
17. Functional reconstitution of the MERS CoV receptor binding motif
18. Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
19. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
20. Half‐life extension of single‐domain antibody–drug conjugates by albumin binding moiety enhances antitumor efficacy
21. Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein
22. Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
23. Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
24. Insights into biological therapeutic strategies for COVID-19
25. Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
26. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells.
27. Effects of preparation method on the biochemical characterization and cytotoxic activity of New Zealand surf clam extracts
28. Development of small-molecule inhibitors against hantaviruses
29. Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate
30. Semisynthesis of homogeneous spike RBD glycoforms from SARS-CoV-2 for profiling the correlations between glycan composition and function
31. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
32. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
33. Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head
34. Antibody Nanotweezer Constructing Bivalent Transistor–Biomolecule Interface with Spatial Tolerance.
35. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
36. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
37. Establishment of Novel Monoclonal Fabs Specific for Epstein-Barr Virus Encoded Latent Membrane Protein 1
38. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
39. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
40. Pretrainable Geometric Graph Neural Network for Antibody Affinity Maturation
41. Structural analysis of the dual agonism at GLP-1R and GCGR
42. Vaccinia virus induces EMT‐like transformation and RhoA‐mediated mesenchymal migration
43. Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants
44. Antibody-based cancer immunotherapy by targeting regulatory T cells
45. Temporal proteomic profiling reveals functional pathways in vaccinia virus-induced cell migration
46. Human monoclonal antibodies as candidate therapeutics against emerging viruses
47. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
48. Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus
49. Fc Engineering: Tailored Synthetic Human IgG1-Fc Repertoire for High-Affinity Interaction with FcRn at pH 6.0
50. Potential Nutraceutical Use of Tribulus terrestris L. in Human Health.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.